Lybrel

Product Category

US FDA-Approved Medicine

Formulation

ETHINYL ESTRADIOL: 0.02 mg LEVONORGESTREL: 0.09 mg 28 oral tablets Inactive ingredients: microcrystalline cellulose, lactose monohydrate, magnesium stearate, polacrilin potassium, hypromellose, titanium dioxide, polyethylene glycol 400, iron oxide, polyethylene glycol 1450, montanic ester wax

Status

Discontinued

ANDA #

021864

Manufacturers